Understand · Treat · Recover
Stem-Cell and Bone Marrow Transplantation
Transplantation is a treatment pathway, not an operation that replaces a bone or the spinal cord.
For patients and families. This education does not replace an individual treatment plan. Do not start, stop or change medicines without the treating team.
Chapter 15 of 20 · H · Treatment options
Two different approaches
Autologous transplantation uses the patient’s collected stem cells to restore blood production after high-dose treatment. Allogeneic transplantation uses donor cells and can add an immune attack against the cancer. Which approach is useful depends on the disease; the two are not interchangeable.
Who may benefit?
The team weighs disease risk, remission status, other treatment options, organ function, infections, fitness and support at home. Ask what transplant adds compared with the best non-transplant option. A transplant can offer a chance of cure in some diseases, but relapse and serious treatment complications remain possible. In myeloma, autologous transplantation usually aims to prolong control.
Donors and preparation
Allogeneic donor selection relies on HLA tissue matching and other clinical factors, not simply the same blood group. A relative is not automatically suitable. The centre will explain sibling, unrelated or partially matched donor options. Before treatment, discuss infection screening, dental needs, fertility preservation, central-line care, accommodation and the full cost of follow-up as well as admission.
Treatment and early recovery
Conditioning treatment is followed by stem cells given through a vein. During recovery, blood counts and infection risk require close supervision. Transfusions and other supportive treatments may be needed. Ask which symptoms require immediate return and how close to the centre the patient must stay. A discharge date is not the same as complete immune recovery.
Graft-versus-host disease and later care
After donor transplantation, donor immune cells can attack healthy tissues: this is graft-versus-host disease. New rash, persistent diarrhea, jaundice, mouth or eye problems and breathing changes should be reported promptly. Take immune-suppressing medicines exactly as directed. Vaccination, infection prevention and organ monitoring follow a transplant-specific plan; routine schedules may need to be restarted or changed.
Take-home message
Ask about expected benefit, major risks and the practical recovery plan before choosing transplant.
Common questions
Does a donor need the same blood group?
Not necessarily. HLA matching and specialist donor selection are more important.
Does engraftment guarantee cure?
No. It shows blood-cell production is recovering, not that relapse and other complications are impossible.
Sources and further reading
Cancer Aware supports patients and families worldwide. Treatment availability, approvals and care pathways vary by country; discuss local options with your healthcare team.